Source: Dalton Transactions. Unidades: FCFRP, FFCLRP, IQ
Subjects: RUTÊNIO, CITOTOXINAS, CÉLULAS, NEOPLASIAS, ALBUMINAS, TRYPANOSOMA CRUZI
ABNT
SILVA, Camila Fontes Neves da et al. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands. Dalton Transactions, n. 45, p. 16440-16452, 2020Tradução . . Disponível em: https://doi.org/10.1039/d0dt01035a. Acesso em: 07 set. 2024.APA
Silva, C. F. N. da, Chrispim, P. B. H., Possato, B., Portapilla, G. B., Rohrabaugh, T. N., Ramos, L. C. B., et al. (2020). Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands. Dalton Transactions, ( 45), 16440-16452. doi:10.1039/d0dt01035aNLM
Silva CFN da, Chrispim PBH, Possato B, Portapilla GB, Rohrabaugh TN, Ramos LCB, Silva RS da, Albuquerque S de, Turro C, Nikolaou S. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands [Internet]. Dalton Transactions. 2020 ;( 45): 16440-16452.[citado 2024 set. 07 ] Available from: https://doi.org/10.1039/d0dt01035aVancouver
Silva CFN da, Chrispim PBH, Possato B, Portapilla GB, Rohrabaugh TN, Ramos LCB, Silva RS da, Albuquerque S de, Turro C, Nikolaou S. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands [Internet]. Dalton Transactions. 2020 ;( 45): 16440-16452.[citado 2024 set. 07 ] Available from: https://doi.org/10.1039/d0dt01035a